François Radvanyi
- Cancer Research top 1%
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 32
- Fibroblast Growth Factor Research 29
- Gene expression and cancer classification 18
- Bioinformatics and Genomic Networks 12
- Surgery top 1%
- Bladder and Urothelial Cancer Treatments 43
- Urinary and Genital Oncology Studies 15
- Genetics top 1%
- Venomous Animal Envenomation and Studies 11
- Oncology top 2%
- Cancer-related Molecular Pathways 10
- Co-authors
- Jean Paul ThieryDominique ChopinEmmanuel BarillotTheodorus van der KwastNicolas StranskyCassian BonXavier Sastre‐GarauIsabelle Bernard‐Pierrot
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
François Radvanyi
148 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 1.3k
- Molecular Biology 5.6k
- Surgery 2.8k
- Genetics 1.5k
- Oncology 1.4k
Countries citing papers authored by François Radvanyi
This map shows the geographic impact of François Radvanyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Radvanyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Radvanyi more than expected).
Fields of papers citing papers by François Radvanyi
This network shows the impact of papers produced by François Radvanyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Radvanyi. The network helps show where François Radvanyi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François Radvanyi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 16 | |
| 7 | 2019 | 14 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 26 | |
| 10 | 2015 | 57 | |
| 11 | 2013 | 109 | |
| 12 | 2012 | 94 | |
| 13 | 2012 | 77 | |
| 14 | 2010 | 78 | |
| 15 | 2010 | 59 | |
| 16 | 2008 | 73 | |
| 17 | 2008 | 114 | |
| 18 | 2007 | 154 | |
| 19 | Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine. | 2003 | 65 |
| 20 | Investigations on the mechanism of action of crotoxin. | 1984 | 8 |
About François Radvanyi
François Radvanyi is a scholar working on Molecular Biology, Cancer Research and Surgery, having authored 154 papers that have together received 8.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (43 papers), Epigenetics and DNA Methylation (32 papers), Fibroblast Growth Factor Research (29 papers), Gene expression and cancer classification (18 papers), Urinary and Genital Oncology Studies (15 papers), Bioinformatics and Genomic Networks (12 papers), Venomous Animal Envenomation and Studies (11 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (5.6k citations) and Surgery (2.8k citations). François Radvanyi has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Jean Paul Thiery, Dominique Chopin, Emmanuel Barillot, Theodorus van der Kwast, Nicolas Stransky, Cassian Bon, Xavier Sastre‐Garau, Isabelle Bernard‐Pierrot, David Cappellen and Sixtina Gil Diez de Medina. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.